TIPS for improving muscle wasting in liver cirrhosis
Part of Brain & nervous system clinical trials.
This study looks at how a treatment called TIPS (a procedure to reduce pressure in the liver) might help improve muscle wasting (sarcopenia) in people with liver cirrhosis. If you are scheduled for TIPS, researchers want to see if it can stop or reverse muscle loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cirrhosis and are scheduled to have a TIPS procedure.
- You are between 18 and 80 years old.
- You are willing to sign a consent form and complete all study tests and follow-up visits.
- You do not have serious heart or brain conditions (like recent heart attack or severe heart failure).
- You do not have an active cancer that is growing or spreading.
- You have not had major surgery or a serious injury in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding branched-chain amino acids (BCAA) to the standard TIPS procedure helps people with cirrhosis and muscle wasting. It aims to see if BCAA can improve outcomes after TIPS.
This trial studies whether a procedure called TIPS (a stent placed in the liver to improve blood flow) can help people with advanced liver disease regain better liver function. It is for patients who have had complications like severe bleeding from the stomach or difficult-to-control fluid buildup (ascites).
This study uses advanced MRI imaging to measure blood flow in the liver and evaluate how well a procedure called TIPS (a small tube placed in the liver) works for managing liver cirrhosis. If you have cirrhosis and may need or are getting TIPS, this trial could help doctors better understand and improve outcomes.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
This study looks at the gut microbiome (the helpful bacteria in your gut) and muscle loss (sarcopenia) in people with liver cirrhosis. It may help researchers understand what changes in the gut and body can go along with getting weaker, so better treatments can be developed.
This study looks at how your body uses protein in your muscles when you have cirrhosis (a scarred liver). It uses a special “tracer” method (a substance that can be tracked) and may help researchers better understand muscle loss in people with milder cirrhosis.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.